Seth Wander

20PUBLICATIONS
154CO-AUTHORS
Biomedical imagingMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 04, 2026
DBT-DINO: Toward Foundation Model-Based Analysis of Digital Breast Tomosynthesis.

|Jul 09, 2026
Beyond amplification: precision approaches to targeting HER2.

|Jul 07, 2026
SERD Wars: Clinical Integration of Emerging Endocrine-Directed and Precision Therapies in Breast Cancer.

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Nov 14, 2025
Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast Cancer.

Hope S Rugo, Virginia Kaklamani, Heather McArthur

|Nov 07, 2025
Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.

Maxwell R Lloyd, Caroline M Weipert, Azka Ali

Pageof 4

Frequent Collaborators

8 joint publications

Aditya Bardia

6 joint publications

Steven J Isakoff

5 joint publications

Leif W Ellisen

5 joint publications

Dejan Juric